ATE481406T1 - Pyrrolochinoxalinonderivate als antibakterielle mittel - Google Patents

Pyrrolochinoxalinonderivate als antibakterielle mittel

Info

Publication number
ATE481406T1
ATE481406T1 AT07727528T AT07727528T ATE481406T1 AT E481406 T1 ATE481406 T1 AT E481406T1 AT 07727528 T AT07727528 T AT 07727528T AT 07727528 T AT07727528 T AT 07727528T AT E481406 T1 ATE481406 T1 AT E481406T1
Authority
AT
Austria
Prior art keywords
pyrroloquinoxalinone
derivatives
antibacterial agents
antibacterial
agents
Prior art date
Application number
AT07727528T
Other languages
English (en)
Inventor
Graham Jones
Timothy Miles
Neil Pearson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0606970A external-priority patent/GB0606970D0/en
Priority claimed from GB0706023A external-priority patent/GB0706023D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE481406T1 publication Critical patent/ATE481406T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07727528T 2006-04-06 2007-03-29 Pyrrolochinoxalinonderivate als antibakterielle mittel ATE481406T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0606970A GB0606970D0 (en) 2006-04-06 2006-04-06 Compounds
GB0706023A GB0706023D0 (en) 2007-03-26 2007-03-26 Compounds
PCT/EP2007/053056 WO2007115947A1 (en) 2006-04-06 2007-03-29 Pyrrolo-quinoxalinone derivatives as antibacterials

Publications (1)

Publication Number Publication Date
ATE481406T1 true ATE481406T1 (de) 2010-10-15

Family

ID=38580721

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727528T ATE481406T1 (de) 2006-04-06 2007-03-29 Pyrrolochinoxalinonderivate als antibakterielle mittel

Country Status (9)

Country Link
US (1) US7709483B2 (de)
EP (1) EP2001887B1 (de)
JP (1) JP2009532423A (de)
AR (1) AR060287A1 (de)
AT (1) ATE481406T1 (de)
DE (1) DE602007009205D1 (de)
PE (1) PE20080182A1 (de)
TW (1) TW200815450A (de)
WO (1) WO2007115947A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2340531T3 (es) * 2005-10-21 2010-06-04 Glaxo Group Limited Compuestos triciclos peri-condensados utiles como agentes antibacterianos.
ATE465163T1 (de) 2005-12-22 2010-05-15 Glaxo Group Ltd Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
AU2008240764C1 (en) * 2007-04-20 2011-10-20 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
CN101874032B (zh) * 2007-11-26 2013-02-06 富山化学工业株式会社 二氮杂萘衍生物一水合物及其制备方法
EP2080761A1 (de) 2008-01-18 2009-07-22 Glaxo Group Limited Verbindungen
ES2411930T3 (es) 2008-02-20 2013-07-09 Actelion Pharmaceuticals Ltd. Compuestos antibióticos azatricíclicos
WO2009141399A1 (en) * 2008-05-23 2009-11-26 Glaxo Group Limited Tricyclic nitrogen containing compounds and their use as antibacterials
CA2725726A1 (en) * 2008-05-23 2009-11-26 Glaxo Group Limited Tricyclic nitrogen containing compounds and their use as antibacterials
DK2344495T3 (en) 2008-10-07 2015-02-02 Actelion Pharmaceuticals Ltd TRICYCLIC OXAZOLIDINON ANTIBIOTIC COMPOUNDS
EP2352734A1 (de) 2008-10-17 2011-08-10 Glaxo Group Limited Als antibakterielle mittel verwendete tricyclische stickstoffverbindungen
AU2009325902B2 (en) 2008-12-12 2015-01-29 Idorsia Pharmaceuticals Ltd 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
CN101870653B (zh) * 2009-04-23 2013-07-10 上海合全药业有限公司 一种2-甲基-3-氟-6-硝基苯甲酸的合成方法
US10702521B2 (en) 2014-08-22 2020-07-07 Glaxosmithkline Intellectual Property Development Limited Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
KR102763767B1 (ko) 2017-11-24 2025-02-05 얀센 파마슈티카 엔브이 피라졸로피리디논 화합물

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603199A (en) * 1982-10-25 1986-07-29 Riker Laboratories, Inc. Phenyl-substituted tricyclic antibacterial agent intermediates
JPS6084287A (ja) * 1983-10-14 1985-05-13 Nissan Chem Ind Ltd キノキザリノン誘導体，その製造法および農園芸用殺菌剤
FR2798656B1 (fr) 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
EP1306038B1 (de) 2000-07-21 2005-12-21 Ljudmila Petrovna Maljuk Teller für stehempfänge
EP1305308B1 (de) 2000-07-26 2006-12-20 Smithkline Beecham Plc Aminopiperidin chinoline und ihre azaisosteren analoga mit antibakterieller wirkung
FR2816618B1 (fr) 2000-11-15 2002-12-27 Aventis Pharma Sa Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
EP1345903A1 (de) 2000-12-21 2003-09-24 Ciba SC Holding AG Kristalline formen von cerivastatin-natrium
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
EP1470131A2 (de) 2002-01-29 2004-10-27 Glaxo Group Limited "aminopiperidinverbindugen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen "
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
GB0217294D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844268B1 (fr) 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
EP1551829B1 (de) 2002-10-10 2010-04-07 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
EP1560488B1 (de) 2002-11-05 2010-09-01 Glaxo Group Limited Antibakterielle mittel
US7232832B2 (en) 2002-11-05 2007-06-19 Smithkline Beecham Corporation Antibacterial agents
AR042486A1 (es) 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
TW200507841A (en) 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
FR2852954B1 (fr) 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
DE10316081A1 (de) 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
WO2004104000A1 (ja) 2003-05-23 2004-12-02 Japan Tobacco Inc. トリサイクリック縮合環化合物およびその医薬用途
FR2858619B1 (fr) 2003-08-08 2006-12-22 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2867472B1 (fr) 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
WO2006002047A2 (en) 2004-06-15 2006-01-05 Glaxo Group Limited Antibacterial agents
FR2872164B1 (fr) 2004-06-29 2006-11-17 Aventis Pharma Sa Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
JP2008505920A (ja) * 2004-07-08 2008-02-28 グラクソ　グループ　リミテッド 抗菌剤
US20080194547A1 (en) 2004-07-09 2008-08-14 Glaxo Group Limited Antibacterial Agents
JP2008506695A (ja) 2004-07-13 2008-03-06 グラクソ　グループ　リミテッド 抗細菌剤
US20070270417A1 (en) 2004-07-22 2007-11-22 Glaxo Group Limited Antibacterial Agents
WO2006017468A2 (en) 2004-08-02 2006-02-16 Glaxo Group Limited Antibacterial agents
JP2008509222A (ja) 2004-08-09 2008-03-27 グラクソ グループ リミテッド 抗菌剤
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
JP4887297B2 (ja) 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質
DE602005021133D1 (de) 2004-10-05 2010-06-17 Actelion Pharmaceuticals Ltd Neue piperidin-antibiotika
JP5314244B2 (ja) 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
US7511035B2 (en) 2005-01-25 2009-03-31 Glaxo Group Limited Antibacterial agents
JP2008528586A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
WO2006081182A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
EP1845995A4 (de) 2005-01-25 2010-03-03 Glaxo Group Ltd Antibakterielle wirkstoffe
JP2008528598A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
WO2006099884A1 (en) 2005-03-24 2006-09-28 Actelion Percurex Ag Beta-aminoalcohol antibiotics
JP5023054B2 (ja) 2005-03-31 2012-09-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗バクテリア剤としての二環式ピラゾール化合物
MX2007014507A (es) 2005-05-24 2008-02-07 Astrazeneca Ab Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana.
ATE441645T1 (de) 2005-05-25 2009-09-15 Actelion Pharmaceuticals Ltd Neue antibiotische derivate
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1900732A4 (de) 2005-06-24 2009-11-18 Toyama Chemical Co Ltd Neue nitrogenierte heterocyclische verbindung und salz davon
ES2340531T3 (es) 2005-10-21 2010-06-04 Glaxo Group Limited Compuestos triciclos peri-condensados utiles como agentes antibacterianos.
ATE465163T1 (de) 2005-12-22 2010-05-15 Glaxo Group Ltd Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
GB0705672D0 (en) 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
PE20080182A1 (es) 2008-05-01
US7709483B2 (en) 2010-05-04
WO2007115947A1 (en) 2007-10-18
EP2001887B1 (de) 2010-09-15
JP2009532423A (ja) 2009-09-10
EP2001887A1 (de) 2008-12-17
US20090062265A1 (en) 2009-03-05
TW200815450A (en) 2008-04-01
AR060287A1 (es) 2008-06-04
DE602007009205D1 (de) 2010-10-28

Similar Documents

Publication Publication Date Title
ATE481406T1 (de) Pyrrolochinoxalinonderivate als antibakterielle mittel
ATE460417T1 (de) Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten
BRPI0720220A2 (pt) Derivados de quinolinas antibacterianos
DK2054030T3 (da) Antimikrobielle midler
ATE443753T1 (de) Nuancierungsmittel
EP2050434A4 (de) Feuchtigkeitsspendendes mittel
DK2034997T3 (da) Antibakterielle sammensætninger
DK2016080T3 (da) Dihydropyrazolopyrimidinon-derivater
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
DK2035394T3 (da) 2-pyrazincarboxamidderivater
EP2072519A4 (de) Diarylketiminderivat
DK1912647T3 (da) Quinolinderivater som antibakterielle midler
ATE544764T1 (de) 5-hydroxymethyloxazolidin-2-onderivate
ATE451356T1 (de) Substituierte arylsulfonamide als antivirale mittel
FI20065388L (fi) Betuliiniperäiset yhdisteet antimikrobisina aineina
DE602007006553D1 (de) Antibakterielle chinolinderivate
DE602006010508D1 (de) Substituierte triazolderivate als oxytocinantagonisten
DK1901743T3 (da) Quinolinderivater som antibakterielle midler
DK1912648T3 (da) Quinolinderivater som antibakterielle midler
ATE509915T1 (de) Antibakterielle chinolinderivate
DE602007006231D1 (de) Antibakterielle chinolinderivate
DK2099760T3 (da) Antibakterielle quinolinderivater
EP2214719A4 (de) Metallofulleren-kontrastmittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties